US Stock MarketDetailed Quotes

Takeda Pharmaceutical (TAK)

Watchlist
  • 18.120
  • -0.090-0.49%
Close Mar 11 15:59 ET
  • 18.120
  • 0.0000.00%
Post 16:10 ET
57.24BMarket Cap81.62P/E (TTM)

Takeda Pharmaceutical (TAK) Revenue Breakdown Overview

By Business/Source

Currency:JPY
2026/Q1
Stock NameRevenueRatio
Research, development, manufacturing, marketing and out-licensing of pharmaceutical products1.11T100.00%

By Country/Region

Currency:JPY
2025/FY
Stock NameRevenueRatio
United States (US)2.38T51.94%
Europe and Canada1.06T23.03%
Japan418.46B9.13%
Latin America235.85B5.15%
China191.74B4.19%
Other128.85B2.81%
Asia (excluding Japan & China)99.39B2.17%
Russia/Commonwealth of Independent States (CIS)72.36B1.58%
View all
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to impact the stock market. Previously, there were indications that Tru Show More